Cowen and Company’s Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share CLAA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,717
Closed -$1.03K 774
2022
Q4
$1.03K Sell
20,717
-47,040
-69% -$3.65K ﹤0.01% 614
2022
Q3
$8K Buy
+67,757
New +$9.34K ﹤0.01% 459

Cowen and Company's CLAA.WS Position: Q1 2023 in Review

Cowen and Company sold out of Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (CLAA.WS) in Q1 2023, closing a stake of 20,717 shares — an estimated $1.03K sold.

Cowen and Company first reported a position in CLAA.WS in Q3 2022 and held it in 2 quarters. The position peaked at $8K in Q3 2022. 0 funds tracked by Wall St. Rank hold CLAA.WS as of Q1 2023.

  • Cowen and Company reported no remaining Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 20,717 Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1.03K.
  • Cowen and Company first reported a position in Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q3 2022 and held it in 2 quarters.
  • Cowen and Company's Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $8K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.